1. Home
  2. Active Ingredient Index
  3. Adalimumab

Active Ingredient Adalimumab

Active Ingredient Details

What is Adalimumab?

A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.

What is the usage for Adalimumab?

Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis).

How many products in the NDC database contain Adalimumab?

The NDC database has 55 products with the active ingredient Adalimumab. The following table lists all the products that have this active ingredient.

NDC Products with Adalimumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0074-1115Proprietary Name: AdalimumabInjection, SolutionAbbvie Inc.ACTIVE
0074-1117Proprietary Name: AdalimumabInjection, SolutionAbbvie Inc.ACTIVE
0074-1867Proprietary Name: AdalimumabLiquidAbbvie Inc.ACTIVE
0074-2330Proprietary Name: AdalimumabInjection, SolutionAbbvie Inc.ACTIVE
50090-6411Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousA-s Medication SolutionsACTIVE
50090-6428Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousA-s Medication SolutionsACTIVE
50090-6704Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6705Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6706Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
50090-6707Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousA-s Medication SolutionsACTIVE
55513-399Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-400Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-410Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-411Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-413Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-479Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-480Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-481Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
55513-482Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen IncACTIVE
58394-051Proprietary Name: AdalimumabLiquidWyeth Biopharma Division Of Wyeth Pharmaceuticals LlcACTIVE
61314-327Proprietary Name: Adalimumab Adalimumab-adazInjection, SolutionSubcutaneousSandoz Inc.ACTIVE
61314-454Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-473Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-476Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-509Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousSandoz IncACTIVE
65219-554Proprietary Name: Idacio AdalimumabInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-556Proprietary Name: Idacio AdalimumabInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
70114-210Proprietary Name: Yusimry Adalimumab-aqvhInjection, SolutionSubcutaneousCoherus Biosciences IncACTIVE
70114-220Proprietary Name: Yusimry Adalimumab-aqvhInjection, SolutionSubcutaneousCoherus Biosciences IncACTIVE
71124-0023Proprietary Name: AdalimumabLiquidSamsung Biologics Co., Ltd.ACTIVE
71124-0027Proprietary Name: AdalimumabLiquidSamsung Biologics Co., Ltd.ACTIVE
72511-400Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen Usa Inc.ACTIVE
72511-482Proprietary Name: Amjevita Adalimumab-attoInjectionSubcutaneousAmgen Usa Inc.ACTIVE
72606-022Proprietary Name: Adalimumab Adalimumab-aatyInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-023Proprietary Name: Yuflyma AdalimumabInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-024Proprietary Name: Yuflyma AdalimumabInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-030Proprietary Name: Yuflyma AdalimumabInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-040Proprietary Name: Adalimumab Adalimumab-aatyInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-041Proprietary Name: Adalimumab Adalimumab-aatyInjectionSubcutaneousCelltrion Usa, Inc.ACTIVE
78206-183Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-184Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-185Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-186Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
78206-187Proprietary Name: Hadlima Adalimumab-bwwdSolutionSubcutaneousOrganon LlcACTIVE
83012-035Proprietary Name: CyltezoLiquidBoehringer Ingelheim Fremont, Inc.ACTIVE
83012-036Proprietary Name: CyltezoLiquidBoehringer Ingelheim Fremont, Inc.ACTIVE
83012-037Proprietary Name: CyltezoLiquidBoehringer Ingelheim Fremont, Inc.ACTIVE
83012-038Proprietary Name: CyltezoLiquidBoehringer Ingelheim Fremont, Inc.ACTIVE
83457-100Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-101Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-102Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-103Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-107Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-108Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-113Proprietary Name: Hyrimoz Adalimumab-adazInjection, SolutionSubcutaneousCordavis LimitedACTIVE
<